The second-line use of CDK4/6 inhibitors in advanced breast cancer saves substantial costs while maintaining health outcomes ...
Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy ...
With breast cancer increasing among younger women, Wellstar partnered with a start-up company specializing in breast cancer screening to help women ages 24 to 39.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback